IL142535A0 - Pharmaceutical compositions for the treatment of inflammation - Google Patents
Pharmaceutical compositions for the treatment of inflammationInfo
- Publication number
- IL142535A0 IL142535A0 IL14253501A IL14253501A IL142535A0 IL 142535 A0 IL142535 A0 IL 142535A0 IL 14253501 A IL14253501 A IL 14253501A IL 14253501 A IL14253501 A IL 14253501A IL 142535 A0 IL142535 A0 IL 142535A0
- Authority
- IL
- Israel
- Prior art keywords
- sub
- inflammation
- treatment
- pharmaceutical compositions
- cis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14253501A IL142535A0 (en) | 2001-04-11 | 2001-04-11 | Pharmaceutical compositions for the treatment of inflammation |
MXPA03009341A MXPA03009341A (es) | 2001-04-11 | 2002-04-11 | ALCOHOLES GRASOS Y ESTERES DE ACIDOS GRASOS UTILES PARA EL TRATAMIENTO DE LA INFLAMACIoN. |
US10/474,447 US20060183797A1 (en) | 2001-04-11 | 2002-04-11 | Fatty alcohols and fatty acid esters useful for treatment of inflammation |
AU2002255241A AU2002255241B2 (en) | 2001-04-11 | 2002-04-11 | Fatty alcohols and fatty acid esters useful for treatment of inflammation |
NZ528784A NZ528784A (en) | 2001-04-11 | 2002-04-11 | Use of an immunomodulator comprising a saturated or cis-unsaturated C10-C18 fatty alcohol useful for treatment of inflammation or disease of the skin |
KR10-2003-7013310A KR20030096312A (ko) | 2001-04-11 | 2002-04-11 | 염증 치료를 위해 유용한 지방 알콜 및 지방산 에스테르 |
PCT/IL2002/000294 WO2002083122A1 (en) | 2001-04-11 | 2002-04-11 | Fatty alcohols and fatty acid esters useful for treatment of inflammation |
CA002442953A CA2442953A1 (en) | 2001-04-11 | 2002-04-11 | Fatty alcohols and fatty acid esters useful for treatment of inflammation |
IL15822702A IL158227A0 (en) | 2001-04-11 | 2002-04-11 | Fatty alcohols and fatty esters useful for treatment of inflammation |
CNB028114892A CN100352433C (zh) | 2001-04-11 | 2002-04-11 | 用于治疗炎症的脂肪醇和脂肪酸酯 |
PL02366586A PL366586A1 (en) | 2001-04-11 | 2002-04-11 | Fatty alcohols and fatty acid esters useful for treatment of inflammation |
AT02724588T ATE475416T1 (de) | 2001-04-11 | 2002-04-11 | Fettalkohole und fettsäureester zur behandlung von entzündungen |
EP02724588A EP1385500B1 (en) | 2001-04-11 | 2002-04-11 | Fatty alcohols and fatty acid esters useful for treatment of inflammation |
HU0303881A HUP0303881A3 (en) | 2001-04-11 | 2002-04-11 | Pharmaceutical compositions containing fatty alcohols and fatty acid esters useful for treatment of inflammation |
JP2002580926A JP2004525180A (ja) | 2001-04-11 | 2002-04-11 | 炎症の治療に有用な脂肪族アルコール及び脂肪酸エステル |
DE60237148T DE60237148D1 (de) | 2001-04-11 | 2002-04-11 | Fettalkohole und fettsäureester zur behandlung von entzündungen |
ZA200307783A ZA200307783B (en) | 2001-04-11 | 2003-10-06 | Fatty alcohols and fatty acid esters useful for treatment of inflammation. |
NO20034558A NO20034558L (no) | 2001-04-11 | 2003-10-10 | Fettalkoholer og fettsyreestere nyttige ved behandling av inflammasjon |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14253501A IL142535A0 (en) | 2001-04-11 | 2001-04-11 | Pharmaceutical compositions for the treatment of inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
IL142535A0 true IL142535A0 (en) | 2002-03-10 |
Family
ID=11075312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14253501A IL142535A0 (en) | 2001-04-11 | 2001-04-11 | Pharmaceutical compositions for the treatment of inflammation |
Country Status (17)
Country | Link |
---|---|
US (1) | US20060183797A1 (xx) |
EP (1) | EP1385500B1 (xx) |
JP (1) | JP2004525180A (xx) |
KR (1) | KR20030096312A (xx) |
CN (1) | CN100352433C (xx) |
AT (1) | ATE475416T1 (xx) |
AU (1) | AU2002255241B2 (xx) |
CA (1) | CA2442953A1 (xx) |
DE (1) | DE60237148D1 (xx) |
HU (1) | HUP0303881A3 (xx) |
IL (1) | IL142535A0 (xx) |
MX (1) | MXPA03009341A (xx) |
NO (1) | NO20034558L (xx) |
NZ (1) | NZ528784A (xx) |
PL (1) | PL366586A1 (xx) |
WO (1) | WO2002083122A1 (xx) |
ZA (1) | ZA200307783B (xx) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL142535A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of inflammation |
IL142536A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Carriers for therapeutic preparations for treatment of t-cell mediated diseases |
DK1385498T3 (da) | 2001-04-18 | 2008-03-25 | Prometic Biosciences Inc | Fedtsyrer som overlevelses- og aktiveringsfaktorer for neutrofiler |
WO2003095667A2 (en) | 2002-05-13 | 2003-11-20 | Arexis Ab | Autoimmune conditions and nadph oxidase defects |
KR20050071565A (ko) | 2002-10-10 | 2005-07-07 | 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 | 지방 알콜의 염기성 에스테르 및 이들의 항염증제 또는면역조절제로서의 용도 |
WO2004069237A1 (en) | 2003-02-07 | 2004-08-19 | Prometic Biosciences Inc. | Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis |
AU2004224332A1 (en) * | 2003-03-20 | 2004-10-07 | Imagenetix, Inc. | Esterified fatty acid composition |
US20050158329A1 (en) | 2004-01-21 | 2005-07-21 | Ghosh Swapan K. | Novel phytol derived immunoadjuvants and their use in vaccine formulations |
KR100767701B1 (ko) * | 2004-04-24 | 2007-10-18 | 김상희 | 모노아세틸디아실글리세롤류 화합물을 유효성분으로 함유하는 면역조절제 및 항암제 |
JP4954450B2 (ja) * | 2004-06-14 | 2012-06-13 | ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス | 弾性繊維形成の不全、欠損又は無秩序による病状に対処するための、リシルオキシダーゼのアイソフォームの活性の誘導 |
CN102050720B (zh) | 2005-05-04 | 2013-03-13 | 普罗诺瓦生物医药挪威公司 | 新的dha衍生物及其作为药物的用途 |
JP5046926B2 (ja) * | 2005-05-16 | 2012-10-10 | 日本水産株式会社 | 炎症性疾患予防又は治療剤 |
US7294739B1 (en) | 2006-11-06 | 2007-11-13 | Teva Pharmacaetical Industries Ltd. | Basic amine esters or oleic acid and their use as anti-inflammatory or immunobodulatory agents |
KR100787765B1 (ko) * | 2006-11-07 | 2007-12-24 | 고려대학교 산학협력단 | 팔미트산을 포함하는 알츠하이머병의 예방 또는 치료용조성물 |
US20100047327A1 (en) * | 2007-01-31 | 2010-02-25 | Tetsuji Kuwahara | Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same |
WO2008106092A1 (en) | 2007-02-26 | 2008-09-04 | Yeda Research And Development Co. Ltd. | Enantiomers of amino-phenyl-acetic acid octadec- 9- (z) enyl ester, their salts and their uses |
WO2008106091A1 (en) * | 2007-02-26 | 2008-09-04 | Yeda Research And Development Co. Ltd. | Use of long-chain alcohol derivatives for the treatment of alopecia areata |
US8697138B2 (en) | 2007-03-28 | 2014-04-15 | Aker Biomarine As | Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders |
ES2415684T3 (es) | 2007-03-28 | 2013-07-26 | Aker Biomarine As | Composiciones de aceite de kril biológicamente eficaces |
EP2299998B1 (en) | 2007-11-02 | 2018-01-03 | Prometic Pharma Smt Limited | Medium-chain length fatty acids and glycerides as nephroprotection agents |
US9239334B2 (en) * | 2008-09-08 | 2016-01-19 | President And Fellows Of Harvard College | Fatty acid C16: 1N7-palmitoleate a lipokine and biomarker for metabolic status |
US8372812B2 (en) | 2009-02-26 | 2013-02-12 | Aker Biomarine Asa | Phospholipid and protein tablets |
EP2272383A1 (en) * | 2009-06-22 | 2011-01-12 | SBAE Industries NV | Composition Comprising Omega-7 and/or Omega-4 Fatty Acids |
AU2014203179C1 (en) | 2013-06-14 | 2017-05-04 | Aker Biomarine Antarctic As | Lipid extraction processes |
US9993549B2 (en) | 2013-10-31 | 2018-06-12 | Hisamitsu Pharmaceutical Co., Inc. | Adjuvant composition, adjuvant preparation containing same, and kit |
GB201400431D0 (en) | 2014-01-10 | 2014-02-26 | Aker Biomarine As | Phospholipid compositions and their preparation |
KR102152850B1 (ko) * | 2014-03-28 | 2020-09-07 | 주식회사 엘지생활건강 | 글리세린 지방산 유도체의 용도 |
AU2016217559A1 (en) | 2015-02-11 | 2017-08-31 | Aker Biomarine Antarctic As | Lipid extraction processes |
BR112017017310B1 (pt) | 2015-02-11 | 2022-07-26 | Aker Biomarine Antarctic As | Composições lipídicas e suplemento alimentar ou nutricional, alimento médico ou funcional e veículo de liberação oral compreendendo as ditas composições |
CA2977237A1 (en) * | 2015-02-18 | 2016-08-25 | Tersus Life Sciences, LLC | Methods for improving joint function |
TWI749016B (zh) | 2016-06-08 | 2021-12-11 | 董宇紅 | 具有奇數碳的脂類化合物及其作為醫藥組合物或者營養補充劑的用途 |
KR101817552B1 (ko) * | 2016-10-13 | 2018-01-11 | 주식회사 엔지켐생명과학 | 모노아세틸디아실글리세롤 화합물을 함유하는 간염의 예방 또는 치료용 조성물 |
CN108853066A (zh) * | 2018-09-20 | 2018-11-23 | 成都中医药大学 | 链式脂肪醇在制备抗炎、镇痛药物中的用途 |
CN112168812B (zh) * | 2019-07-02 | 2022-07-08 | 瑞微(深圳)生物科技有限公司 | 棕榈油酸用于制备预防或治疗炎症性疾病的组合物的用途 |
CN114544783B (zh) * | 2020-11-20 | 2024-01-30 | 上海交通大学医学院附属瑞金医院 | 一种预防银屑病复发的内源性代谢物组合 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US612700A (en) * | 1898-10-18 | Disk plow | ||
US6458772B1 (en) * | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
US3592930A (en) * | 1968-07-19 | 1971-07-13 | Syntex Corp | Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle |
US4152423A (en) * | 1971-11-19 | 1979-05-01 | Agence Nationale De Valorisation De La Recherche (Anvar) | Immunological agents |
US4258029A (en) * | 1979-04-23 | 1981-03-24 | Connaught Laboratories Limited | Synthetic adjuvants for stimulation of antigenic responses |
WO1985001890A1 (en) * | 1983-10-26 | 1985-05-09 | Kanebo, Ltd. | Proteinous emulsifier, process for its preparation, and emulsified cosmetic preparation containing same |
CH679119A5 (xx) * | 1988-05-13 | 1991-12-31 | Sandoz Ag | |
US5540931A (en) * | 1989-03-03 | 1996-07-30 | Charles W. Hewitt | Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
US5194451A (en) * | 1989-11-02 | 1993-03-16 | Katz David H | Systemic anti-inflammatory treatment |
IE904098A1 (en) * | 1989-11-13 | 1991-05-22 | Nova Pharm Corp | Lipospheres for controlled delivery of substances |
US5817629A (en) * | 1991-10-22 | 1998-10-06 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
TW355153B (en) * | 1996-05-21 | 1999-04-01 | Toshiba Machine Co Ltd | A method for leveling abrasive cloth and device for the same |
ATE299700T1 (de) * | 1996-09-17 | 2005-08-15 | Avanir Pharmaceuticals | Langkettige alkohole, alkane, fettsäuren und amide als vireninhibitoren |
US6331568B1 (en) * | 1996-10-11 | 2001-12-18 | Scotia Holdings Plc. | Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
US5910306A (en) * | 1996-11-14 | 1999-06-08 | The United States Of America As Represented By The Secretary Of The Army | Transdermal delivery system for antigen |
US6210700B1 (en) * | 1997-01-14 | 2001-04-03 | Novartis Nutrition Ag | Enhancement of transplant graft survival through nutritional immunomodulation with omega-9 fatty acid dietary supplement therapy |
US6242426B1 (en) * | 1997-07-25 | 2001-06-05 | Avigen, Inc. | Induction of immune response to antigens expressed by recombinant adeno-associated virus |
US6114337A (en) * | 1998-11-27 | 2000-09-05 | Pugliese; Peter T. | Zwitteronic-fatty acid compounds having anti-inflammatory properties |
EP0919230A1 (en) * | 1997-12-01 | 1999-06-02 | Societe Des Produits Nestle S.A. | NMIFA's as anti-inflammatory agents in superficial mammal tissues |
US5968524A (en) * | 1997-12-23 | 1999-10-19 | Genesis Research & Development Corp. | Methods and compounds for the treatment of immunologically-mediated psoriasis |
WO1999058120A1 (en) * | 1998-05-08 | 1999-11-18 | Rolf Berge | USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS |
US6673908B1 (en) * | 1999-02-22 | 2004-01-06 | Nuvelo, Inc. | Tumor necrosis factor receptor 2 |
US6118020A (en) * | 1999-05-19 | 2000-09-12 | Nexmed Holdings, Inc. | Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate |
PT1194109E (pt) * | 1999-06-25 | 2004-12-31 | Durham Pharmaceuticals Ltd | Formulacoes topicas compreendendo agentes de penetracao na pele e utilizacao dasmesmas |
IL142535A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of inflammation |
IL142536A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Carriers for therapeutic preparations for treatment of t-cell mediated diseases |
KR20050071565A (ko) * | 2002-10-10 | 2005-07-07 | 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 | 지방 알콜의 염기성 에스테르 및 이들의 항염증제 또는면역조절제로서의 용도 |
-
2001
- 2001-04-11 IL IL14253501A patent/IL142535A0/xx unknown
-
2002
- 2002-04-11 CA CA002442953A patent/CA2442953A1/en not_active Abandoned
- 2002-04-11 KR KR10-2003-7013310A patent/KR20030096312A/ko not_active Application Discontinuation
- 2002-04-11 US US10/474,447 patent/US20060183797A1/en not_active Abandoned
- 2002-04-11 PL PL02366586A patent/PL366586A1/xx not_active Application Discontinuation
- 2002-04-11 AU AU2002255241A patent/AU2002255241B2/en not_active Ceased
- 2002-04-11 EP EP02724588A patent/EP1385500B1/en not_active Expired - Lifetime
- 2002-04-11 DE DE60237148T patent/DE60237148D1/de not_active Expired - Lifetime
- 2002-04-11 NZ NZ528784A patent/NZ528784A/en unknown
- 2002-04-11 CN CNB028114892A patent/CN100352433C/zh not_active Expired - Fee Related
- 2002-04-11 HU HU0303881A patent/HUP0303881A3/hu unknown
- 2002-04-11 JP JP2002580926A patent/JP2004525180A/ja active Pending
- 2002-04-11 WO PCT/IL2002/000294 patent/WO2002083122A1/en active IP Right Grant
- 2002-04-11 MX MXPA03009341A patent/MXPA03009341A/es active IP Right Grant
- 2002-04-11 AT AT02724588T patent/ATE475416T1/de not_active IP Right Cessation
-
2003
- 2003-10-06 ZA ZA200307783A patent/ZA200307783B/en unknown
- 2003-10-10 NO NO20034558A patent/NO20034558L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20030096312A (ko) | 2003-12-24 |
EP1385500A1 (en) | 2004-02-04 |
NO20034558L (no) | 2003-12-10 |
CA2442953A1 (en) | 2002-10-24 |
HUP0303881A3 (en) | 2009-10-28 |
ATE475416T1 (de) | 2010-08-15 |
ZA200307783B (en) | 2004-10-06 |
CN1514723A (zh) | 2004-07-21 |
JP2004525180A (ja) | 2004-08-19 |
EP1385500B1 (en) | 2010-07-28 |
HUP0303881A2 (hu) | 2004-03-01 |
WO2002083122A1 (en) | 2002-10-24 |
CN100352433C (zh) | 2007-12-05 |
MXPA03009341A (es) | 2004-02-12 |
US20060183797A1 (en) | 2006-08-17 |
AU2002255241B2 (en) | 2007-08-02 |
PL366586A1 (en) | 2005-02-07 |
NZ528784A (en) | 2007-06-29 |
EP1385500A4 (en) | 2004-12-29 |
DE60237148D1 (de) | 2010-09-09 |
NO20034558D0 (no) | 2003-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL142535A0 (en) | Pharmaceutical compositions for the treatment of inflammation | |
DE60237358D1 (xx) | ||
TNSN01108A1 (en) | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids | |
WO2003013497A1 (fr) | Compositions s'averant efficaces pour prevenir ou soulager des troubles ou maladies provoques par une hypofonction cerebrale | |
WO2002094210A3 (de) | Kosmetische mittel | |
HK1102348A1 (en) | Composition containing polyglycerol/medium-chain fatty acid ester | |
MY127430A (en) | Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols | |
ATE279209T1 (de) | Injizierbare pharmazeutische zusammensetzung zur systemischen verabreichung pharmakologisch aktiver wirkstoffe enthaltend mittelkettige triglyceride | |
IL210233A (en) | Formulation of omega-3 fatty acid containing epa and dha and no other active ingredients other than omega-3 fatty acids | |
IS2180B (is) | Lyfjasamsetning sem inniheldur eikósapentaensýru og/eða steridónsýru | |
ATE422350T1 (de) | Anisinsäure und glyceride enthaltende zusammensetzungen | |
UY26303A1 (es) | Composiciones farmacéuticas para administración oral y tópica | |
AU5629701A (en) | Pourable shortening composition | |
SG149825A1 (en) | Body taste improver comprising long-chain highly unsaturated fatty acid and/or ester thereof | |
EP1408951A4 (en) | ANTI-FLAMMABILITY FATTY ALCOHOLS AND FATTY ACID ESTERS AS ANTIGENS | |
MY161871A (en) | Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester | |
CA2404480A1 (en) | Compositions containing polycarbonate | |
AU2002323075A1 (en) | New methods for the preparation of propylene glycol fatty acid esters | |
WO2002049582A3 (de) | Kosmetische und dermatologische lichtschutzformulierungen mit einem gehalt an benzotriazolderivaten und oberflächenaktiven zitronensäureestern | |
IT1292126B1 (it) | Esteri cerosi arricchiti in acidi grassi omega-3 insaturi,loro preparazione ed uso | |
IL144706A0 (en) | Ether type lipid a-1 carboxylic acid analogue and pharmaceutical compositions containing the same | |
AU2002331561A1 (en) | Low odor composition for lactate esters and other ester biosolvents |